Selected research
Industry Growth & Trends
Global Antidiuretic Hormone (ADH) Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Antidiuretic Hormone (ADH) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Antidiuretic Hormone (ADH) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Antidiuretic Hormone (ADH) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Antidiuretic Hormone (ADH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Antidiuretic Hormone (ADH) market include Shanghai Soho-Yiming Pharmaceuticals, Novartis, Pfizer, Ferring Pharmaceuticals, Fresenius Kabi, Par Pharmaceutical and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Antidiuretic Hormone (ADH) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Antidiuretic Hormone (ADH) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antidiuretic Hormone (ADH) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antidiuretic Hormone (ADH).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Antidiuretic Hormone (ADH) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Antidiuretic Hormone (ADH) Market by Company
Shanghai Soho-Yiming Pharmaceuticals
Novartis
Pfizer
Ferring Pharmaceuticals
Fresenius Kabi
Par Pharmaceutical
Astellas Pharma
Antidiuretic Hormone (ADH) Segment by Type
Subcutaneous Injection
Intravenous Injection
Intramuscular Injection
Antidiuretic Hormone (ADH) Segment by Application
Vasodilatory Shock
Gastrointestinal Bleeding
Ventricular Tachycardia & Fibrillation
Anti-Diuretic Hormone Deficiency
Antidiuretic Hormone (ADH) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiuretic Hormone (ADH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antidiuretic Hormone (ADH) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiuretic Hormone (ADH).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Antidiuretic Hormone (ADH) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Subcutaneous Injection
- Intravenous Injection
- Intramuscular Injection
Applications
- Vasodilatory Shock
- Gastrointestinal Bleeding
- Ventricular Tachycardia & Fibrillation
- Anti-Diuretic Hormone Deficiency
Companies covered
- Shanghai Soho-Yiming Pharmaceuticals
- Novartis
- Pfizer
- Ferring Pharmaceuticals
- Fresenius Kabi
- Par Pharmaceutical
- Astellas Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Antidiuretic Hormone (ADH) Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Antidiuretic Hormone (ADH) Market Size by Region (2021-2032)
- 1.4.1 Global Antidiuretic Hormone (ADH) Market Size by Region (2021-2026)
- 1.4.2 Global Antidiuretic Hormone (ADH) Market Size by Region (2027-2032)
- 1.5 Key Regions Antidiuretic Hormone (ADH) Market Size (2021-2032)
- 1.5.1 North America Antidiuretic Hormone (ADH) Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Antidiuretic Hormone (ADH) Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Antidiuretic Hormone (ADH) Market Size Growth Rate (2021-2032)
- 1.5.4 South America Antidiuretic Hormone (ADH) Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Antidiuretic Hormone (ADH) Market Size Growth Rate (2021-2032)
2 Antidiuretic Hormone (ADH) Market by Type
- 2.1 Type Introduction
- 2.1.1 Subcutaneous Injection
- 2.1.2 Intravenous Injection
- 2.1.3 Intramuscular Injection
- 2.2 Global Antidiuretic Hormone (ADH) Market Size by Type
- 2.2.1 Global Antidiuretic Hormone (ADH) Market Size Overview by Type (2021-2032)
- 2.2.2 Global Antidiuretic Hormone (ADH) Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Antidiuretic Hormone (ADH) Market Size Forecasted by Type (2027-2032)
- 2.3 Global Antidiuretic Hormone (ADH) Market Size by Regions
- 2.3.1 North America Antidiuretic Hormone (ADH) Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Antidiuretic Hormone (ADH) Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Antidiuretic Hormone (ADH) Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Antidiuretic Hormone (ADH) Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Antidiuretic Hormone (ADH) Market Size Breakdown by Type (2021-2026)
3 Antidiuretic Hormone (ADH) Market by Application
- 3.1 Type Introduction
- 3.1.1 Vasodilatory Shock
- 3.1.2 Gastrointestinal Bleeding
- 3.1.3 Ventricular Tachycardia & Fibrillation
- 3.1.4 Anti-Diuretic Hormone Deficiency
- 3.2 Global Antidiuretic Hormone (ADH) Market Size by Application
- 3.2.1 Global Antidiuretic Hormone (ADH) Market Size Overview by Application (2021-2032)
- 3.2.2 Global Antidiuretic Hormone (ADH) Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Antidiuretic Hormone (ADH) Market Size Forecasted by Application (2027-2032)
- 3.3 Global Antidiuretic Hormone (ADH) Market Size by Regions
- 3.3.1 North America Antidiuretic Hormone (ADH) Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Antidiuretic Hormone (ADH) Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Antidiuretic Hormone (ADH) Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Antidiuretic Hormone (ADH) Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Antidiuretic Hormone (ADH) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Antidiuretic Hormone (ADH) Industry Trends
- 4.2 Antidiuretic Hormone (ADH) Industry Drivers
- 4.3 Antidiuretic Hormone (ADH) Industry Opportunities and Challenges
- 4.4 Antidiuretic Hormone (ADH) Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Antidiuretic Hormone (ADH) Revenue (2021-2026)
- 5.2 Global Antidiuretic Hormone (ADH) Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Antidiuretic Hormone (ADH) Key Company Headquarters & Area Served
- 5.4 Global Antidiuretic Hormone (ADH) Company, Product Type & Application
- 5.5 Global Antidiuretic Hormone (ADH) Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Antidiuretic Hormone (ADH) Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Antidiuretic Hormone (ADH) Players Market Share by Revenue in 2025
- 5.6.3 2025 Antidiuretic Hormone (ADH) Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Shanghai Soho-Yiming Pharmaceuticals
- 6.1.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
- 6.1.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
- 6.1.3 Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio
- 6.1.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
- 6.2 Novartis
- 6.2.1 Novartis Company Information
- 6.2.2 Novartis Business Overview
- 6.2.3 Novartis Antidiuretic Hormone (ADH) Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Novartis Antidiuretic Hormone (ADH) Product Portfolio
- 6.2.5 Novartis Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Antidiuretic Hormone (ADH) Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Pfizer Antidiuretic Hormone (ADH) Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 Ferring Pharmaceuticals
- 6.4.1 Ferring Pharmaceuticals Company Information
- 6.4.2 Ferring Pharmaceuticals Business Overview
- 6.4.3 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio
- 6.4.5 Ferring Pharmaceuticals Recent Developments
- 6.5 Fresenius Kabi
- 6.5.1 Fresenius Kabi Company Information
- 6.5.2 Fresenius Kabi Business Overview
- 6.5.3 Fresenius Kabi Antidiuretic Hormone (ADH) Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Fresenius Kabi Antidiuretic Hormone (ADH) Product Portfolio
- 6.5.5 Fresenius Kabi Recent Developments
- 6.6 Par Pharmaceutical
- 6.6.1 Par Pharmaceutical Company Information
- 6.6.2 Par Pharmaceutical Business Overview
- 6.6.3 Par Pharmaceutical Antidiuretic Hormone (ADH) Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Par Pharmaceutical Antidiuretic Hormone (ADH) Product Portfolio
- 6.6.5 Par Pharmaceutical Recent Developments
- 6.7 Astellas Pharma
- 6.7.1 Astellas Pharma Company Information
- 6.7.2 Astellas Pharma Business Overview
- 6.7.3 Astellas Pharma Antidiuretic Hormone (ADH) Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Astellas Pharma Antidiuretic Hormone (ADH) Product Portfolio
- 6.7.5 Astellas Pharma Recent Developments
7 North America
- 7.1 North America Antidiuretic Hormone (ADH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 7.3 North America Antidiuretic Hormone (ADH) Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Antidiuretic Hormone (ADH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 8.3 Europe Antidiuretic Hormone (ADH) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Antidiuretic Hormone (ADH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Antidiuretic Hormone (ADH) Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Antidiuretic Hormone (ADH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 10.3 South America Antidiuretic Hormone (ADH) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Antidiuretic Hormone (ADH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Antidiuretic Hormone (ADH) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst